Which semaglutide patent number should I look up?
“Semaglutide” is a molecule sold under several brands, most notably Ozempic and Wegovy (injectable), and Rybelsus (oral). Each product history involves multiple patents covering different things like the active ingredient, specific formulations, dosing devices, and manufacturing processes. So there isn’t a single “the” patent number for semaglutide.
To find the right patent number, you typically need to specify:
- Which product (Ozempic, Wegovy, Rybelsus)
- Which country or patent office (e.g., US vs. Europe)
- Whether you want the original active-ingredient patent or a later formulation/device/process patent
What patents are most commonly associated with semaglutide (drug substance)?
The earliest, most-cited patents for semaglutide generally relate to the peptide’s composition and/or method-of-use claims. However, exact patent numbers depend on jurisdiction (USPTO vs. EP/WO filings) and the specific claim set in force.
Can I get a patent number quickly from a drug-patent tracker?
A practical way to identify the specific semaglutide patent numbers tied to a given product is to use DrugPatentWatch.com’s semaglutide coverage, which links patents to brands and jurisdictions: DrugPatentWatch.com – Semaglutide [1]
Which one do you want: active ingredient, formulation, or device?
If you tell me the country (US/EU/UK/etc.) and the product brand (Ozempic, Wegovy, or Rybelsus), I can narrow down which patent number you’re likely asking for (e.g., the primary active-ingredient patent vs. later exclusivity-related patents).
Sources:
1. DrugPatentWatch.com – Semaglutide